A Search Service for Abbreviation / Long Form

■ Related PubMed/MEDLINE Info.

[Related PubMed/MEDLINE]
Total Number of Papers: 1715
[Display Entries]
100 entries :
      (Publication year, Descending)
100 entries :
      (Publication year, Ascending)
all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation : ARB
Long Form : angiotensin receptor blocker
No. Year Title Co-occurring Abbreviation
2020 ACE inhibitor-mediated angioedema. ACEi-AE, AE
2020 Adherence to heart failure management medications following cardiac resynchronization therapy. ACEI, BB, CRT, GDMT, HF, PDC
2020 Analysis of situation of acute coronary syndrome based on the date of the Improving Care for Cardiovascular Disease in China-Acute Coronary Syndrome (CCC-ACS) project: single-centre observational study. ACEI, CCC, D-to-B, D-to-N, STEMI
2020 Angiotensin II and angiotensin 1-7: which is their role in atrial fibrillation? ACEI, AF, AII, EAT, RAS
2020 Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers as therapeutic options in the treatment of renal cancer: A meta-analysis. ACEI, HR
2020 Antihypertensive agents in Alzheimer's disease: beyond vascular protection. ACEI, AD, CCB
2020 Antihypertensive medications are associated with the risk of kidney and bladder cancer: a systematic review and meta-analysis. RR
2020 Asian management of hypertension: Current status, home blood pressure, and specific concerns in Philippines (a country report). CAD, CCB, CVD
2020 Clinical and biochemical indexes from 2019-nCoV infected patients linked to viral loads and lung injury. ALB, ARDS, CRP, LDH, LYM, Neu
10  2020 Comparative Effectiveness of Sacubitril-ValsartanVersus ACE/ARB Therapy in Heart Failure With ReducedEjection Fraction. ACE, CI, HF, HR
11  2020 Continuation of Angiotensin-Converting Enzyme Inhibitors on the Day of Surgery Is Not Associated With Increased Risk of Hypotension Upon Induction of General Anesthesia in Elective Noncardiac Surgeries. ACEI
12  2020 Effects of an Antihypertensive Combination in Japanese Hypertensive Outpatients Based on the Long-Acting Calcium Channel Blocker Benidipine on Vascular and Renal Events: A Sub-Analysis of the COPE Trial. ---
13  2020 Effects of angiotensin-converting enzyme inhibitor/angiotensin receptor blocker use on cancer therapy-related cardiac dysfunction: a meta-analysis of randomized controlled trials. ACEI, CTRCD, RCTs, RR
14  2020 Effects of Blood Pressure Lowering Agents on Cardiovascular Outcomes in Weight Excess Patients: A Systematic Review and Meta-analysis. ACEI, BB, CCB, CI, HF, HR, MI, RR
15  2020 Effects of renin-angiotensin system blockers on renal and cardiovascular outcomes in patients with diabetic nephropathy: a meta-analysis of randomized controlled trials. ACEI, CIs, DN, ESRD, MACEs, MI, RCTs, RR
16  2020 Favorable five-year outcomes for heart failure diagnosed in younger patients without severe comorbidity. ACEI, HF
17  2020 Genome-wide association study of angioedema induced by angiotensin-converting enzyme inhibitor and angiotensin receptor blocker treatment. ACEI
18  2020 Hemodynamic Impact of Cardiovascular Antihypertensive Medications in Patients With Sepsis-Related Acute Circulatory Failure. ACEI, BB, CCB, ICU
19  2020 Impact of renin-angiotensin system blockade on the prognosis of acute coronary syndrome based on left ventricular ejection fraction. ACEI, ACS, LVEF, PCI
20  2020 Implementation of Guideline-Recommended Therapies for Patients With Heart Failure and Reduced Ejection Fraction: A Regional Arab Middle East Experience. ACEI, ARNI, HFrEF, LVEF, MRA
21  2020 Mineralocorticoid Receptor Antagonists and Renal Outcomes in Heart Failure Patients with and without Chronic Kidney Disease. ACEI, CKD, HF, MRAs
22  2020 Pharmacological interventions for heart failure in people with chronic kidney disease. ACEI, CI, CKD, RR
23  2020 Prior HeartFailure Hospitalization, Clinical Outcomes, and Response to Sacubitril/Valsartan Compared With Valsartan in HFpEF. ARNI, HF, HFpEF
24  2020 Risk factors associated with biochemically detected and hospitalised acute kidney injury in patients prescribed renin angiotensin system inhibitors. ACEI, AKI, CKD, DM, HF, PY
25  2020 The effects of losartan versus beta-blockers on cardiovascular protection in marfan syndrome: A systematic review and meta-analysis. BB, CI, MFS, OR, SMD
26  2020 The eligible population of the PARADIGM-HF trial in a real-world outpatient clinic and its cardiovascular risk between 2005 and 2016. ACEI, ARNI
27  2020 The influence of iatrogenic atrial septal defect on the prognosis of patients with atrial fibrillation between cryoablation and radiofrequency ablation. ACEI, AF, LAD, SD, SR
28  2020 [Primary prevention of coronary heart disease : Evidence-based drug treatment]. ACE, CAD, DPP-4, GLP-1, PCSK-9, SGLT2
29  2019 "Real World" Eligibility for Sacubitril/Valsartan in Unselected Heart Failure Patients: Data from the Swedish Heart Failure Registry. ACEI, HFrEF, SwedeHF
30  2019 A comparison between statin with ACE inhibitor or ARB therapy in STEMI patients who underwent successful PCI with drug-eluting stents. ACEI, CI, DES, HR, MACE, PCI, PSM, re-MI, STEMI, TVF
31  2019 A per-protocol initiation of sacubitril/valsartan in an advanced heart failure disease management programme in the Middle East Gulf Region. ACEI
32  2019 A randomized controlled trial comparing methohexital and propofol for induction in patients receiving angiotensin axis blockade. AAB, ACEI
33  2019 Absence of left bundle branch block and blood urea nitrogen predict improvement in left ventricular ejection fraction in patients with cardiomyopathy and wearable cardioverter defibrillators. ACEI, BUN, CI, ICD, IQR, LVEF, OR, WCDs
34  2019 ACE2 exhibits protective effects against LPS-induced acute lung injury in mice by inhibiting the LPS-TLR4 pathway. ACE2, ACEI, ALI, AT1R, DMF, LPS
35  2019 Adherence to ESC guideline-recommended medications over a 36-month follow-up period after hospitalization for heart failure: Results from the EPICAL2 cohort study. ACEI, BB, ESC, HFrEF, MRAs, RAS
36  2019 Advanced Approaches Based on Expression of Different Genes and Biomarkers for the Diagnosis and Treatment of Renal Disorders. ACEI, CKD
37  2019 An electronic tool to aid community pharmacists in optimizing care for persons with diabetes. ACEI
38  2019 Anemia is an independent risk factor for cardiovascular and renal events in hypertensive outpatients with well-controlled blood pressure: a subgroup analysis of the ATTEMPT-CVD randomized trial. ---
39  2019 Angiotensin axis blockade, acute kidney injury, and perioperative morbidity in patients undergoing colorectal surgery: A retrospective cohort study. ACEI, AKI
40  2019 Angiotensin II receptor blockers and gastrointestinal adverse events of resembling sprue-like enteropathy: a systematic review. HLA
41  2019 Angiotensin Receptor Blockers for Erectile Dysfunction in Hypertensive Men: A Brief Meta-Analysis of Randomized Control Trials. CI, MD, RCTs
42  2019 Angiotensin-neprilysin inhibition confers renoprotection in rats with diabetes and hypertension by limiting podocyte injury. ARNI
43  2019 Anti-Hypertensive Effect of Sacubitril/Valsartan: A Meta-Analysis of Randomized Controlled Trials. ACEI, AEs, CCB, CI, maSBP, RCTs, WMD
44  2019 Antihypertensive agents: a long way to safe drug prescribing in children. ACEI, CCB
45  2019 Antihypertensive effect of sacubitril/valsartan: a meta-analysis. maSBP, msSBP, RCTs, WMD
46  2019 Antihypertensive therapy prescribing patterns and correlates of blood pressure control among hypertensive patients with chronic kidney disease. ACEI, BB, BP, CKD, EHRs, RHTN
47  2019 Antiproteinuria Effect of Calcitriol in Patients With Chronic Kidney Disease and Vitamin D Deficiency: A Randomized Controlled Study. ACEI, CKD, uPCR
48  2019 Association of Angiotensin Modulators With the Course of Idiopathic Pulmonary Fibrosis. ACEI, HR, IPF
49  2019 Calcium Channel Blockers in Restoration of Endothelial Function: Systematic Review and Meta-Analysis of Randomized Controlled Trials. ACEI, CCB, EF, FMD
50  2019 Causes and impact on survival of underuse of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in heart failure. ACEI, HFrEF, LVEF, SCr
51  2019 Clinical experiences and case review of angiotensin II receptor blocker-related angioedema in Korea. ---
52  2019 Clinical Features and Outcomes Associated with Angioedema in the Emergency Department. ACEI, CI, ED, OR
53  2019 Comparison between angiotensin-converting enzyme inhibitor and angiotensin receptor blocker after percutaneous coronary intervention. ACEI, CAD, CI, HR, PCI, RAAS
54  2019 Comparison Between Beta-Blockers with Angiotensin-Converting Enzyme Inhibitors and Beta-Blockers with Angiotensin II Type I Receptor Blockers in ST-Segment Elevation Myocardial Infarction After Successful Percutaneous Coronary Intervention with Drug-Eluting Stents. ACEI, BB, CD, CI, DES, HR, MACE, PCI, PSM, re-MI, STEMI, TLR, TVR
55  2019 Concurrent neprilysin inhibition and renin-angiotensin system modulations prevented diabetic nephropathy. ACE2, DIZE, DN, NEPi, NPS, RAS
56  2019 Determinants of prolonged hospitalization in patients who underwent trans-femoral transcatheter aortic valve implantation. ACE, AS, eGFR, TAVI
57  2019 Discharge treatment with angiotensin-converting enzyme inhibitor/angiotensin receptor blocker after a heart failure hospitalisation is associated with a better prognosis irrespective of left ventricular ejection fraction. ACE, CI, HF, HFmrEF, HFpEF, HFrEF, HR, LVEF
58  2019 Doses of renin-angiotensin system inhibitors but not beta-blockers predict outcome after ST-elevation myocardial infarction. ACEI, LVEDVI, STEMI
59  2019 Drug therapies for patients with IgA nephropathy: A network meta-analysis of randomized clinical trials. ACEI, IgAN
60  2019 Effect of Angiotensin II Inhibitors on Gastrointestinal Bleeding in Patients With LeftVentricular Assist Devices. ACE, aHR, AVM, CF-LVAD, CI, GIB, TGF
61  2019 Effect of angiotensin receptor blockers on blood pressure and renal function in patients with concomitant hypertension and chronic kidney disease: a systematic review and meta-analysis. BP, CIs, CKD, CrCl, eGFR, SCr
62  2019 Effect of Switching to Azilsartan From Fixed-Dose Combination of an Angiotensin II Receptor Blocker and Calcium Channel Blocker or a Thiazide in Patients With Hypertension. BP, HCT
63  2019 Effects of Angiotensin-Converting Enzyme Inhibitors and Angiotensin-Receptor Blockers in Heart Failure With Chronic Kidney Disease - Propensity Score Matching Analysis. ACEI, CKD, HF
64  2019 Effects of Antihypertensive Drugs on Outcomes of Breast Reconstruction. DIEP
65  2019 Effects of combination drugs on antihypertensive medication adherence in a real-world setting: a Korean Nationwide Study. CCB, MPCs, MPR, SPCs
66  2019 Effects of European Society of Cardiology guidelines on medication profiles after hospitalization for heart failure in 22,476 Dutch patients: from 2001 until 2015. ACEI, BB, HF, MRA, NYHA
67  2019 Effects of valsartan, benazepril and their combination in overt nephropathy of type 2 diabetes: A prospective, randomized, controlled trial. ACE, CI, ESRD, HR
68  2019 Efficacy and safety of a combination antihypertensive drug (olmesartan plus azelnidipine): "Issues with hypertension studies in real-world practice". AZ, BP, CCB, OL, PR
69  2019 Efficacy and Safety of Dual Blockade of the Renin-Angiotensin-Aldosterone System in Diabetic Kidney Disease: A Meta-Analysis. ACEI, DKD, DRI, ESRD, GFR, RAAS, RCTs
70  2019 Efficacy and Safety of Renin-Angiotensin Aldosterone System Inhibitor in Patients with IgA Nephropathy: A Meta-Analysis of Randomized Controlled Trials. ACEI, IgAN, RCTs
71  2019 Efficacy of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers in the Preventative Treatment of Episodic Migraine in Adults. ACE inhibitors, RCT
72  2019 Efficacy of Sacubitril/Valsartan in Hypertension. DBP, RCTs
73  2019 Evaluation of Prescription Adaptation Following Changes to A Provincial Drug Insurance Formulary. ACEI, BC, CCB, FPs, NPs
74  2019 Fibroblast Growth Factor-23, Heart Failure Risk, and Renin-Angiotensin-Aldosterone-System Blockade in Hypertension: The MESA Study. ACEI, FGF23, HF, MESA
75  2019 Fimasartan for Remodeling after Myocardial Infarction. MI
76  2019 Folate-Modified Liposomes Loaded with Telmisartan Enhance Anti-Atherosclerotic Potency for Advanced Atherosclerosis in ApoE-/- Mice. FRbeta, TEL
77  2019 Hemilingual Angioedema after Thrombolysis in a Patient on an Angiotensin II Receptor Blocker. OLAE
78  2019 High blood pressure in dementia: How low can we go? CCB
79  2019 Hypertension after Kidney Transplantation: Clinical Significance and Therapeutical Aspects. ACE, CCB, CNI
80  2019 Impact of Angiotensin II Signaling Blockade on Clinical Outcomes in Patients with Inflammatory Bowel Disease. ACEI, IBD, RAS
81  2019 Impact of Metabolic Syndrome Diagnosis and Its Treatment on Survival of Colorectal Cancer Patients. ACEI, CRC, MetS, OS
82  2019 Impact of the Diabetes Canada Guideline Dissemination Strategy on the Prescription of Vascular Protective Medications: A Retrospective Cohort Study, 2010-2015. ACEI, CPCSSN, PPI
83  2019 Inhibition of the renin-angiotensin system in the cardiorenal syndrome with anaemia: a double-edged sword. ACEI, GFR, RAS
84  2019 Innovations in pharmacological treatment of heart failure. SGLT2
85  2019 Interpreting stimulated plasma renin and aldosterone to select physiologically individualized therapy for resistant hypertension: importance of the class of stimulating drugs. ACEI, PRA
86  2019 Interrupting providers with clinical decision support to improve care for heart failure. ACE, CDS
87  2019 Interventions for idiopathic steroid-resistant nephrotic syndrome in children. ACEI, CI, CNI, CPA, GFR, MD, MMF, RCTs, RR, SRNS
88  2019 Lesson Learnt from Recall of Valsartan and Other Angiotensin II Receptor Blocker Drugs Containing NDMA and NDEA Impurities. NDEA, NDMA
89  2019 Level and variation on quality of care in China: a cross-sectional study for the acute myocardial infarction patients in tertiary hospitals in Beijing. ACEI, AMI, LVSD, PCI, QoC
90  2019 Long-term clinical outcome between beta-blocker with ACEI or ARB in patients with NSTEMI who underwent PCI with drug-eluting stents. ACEI, BB, DES, MACE, NSTEMI, PCI, PSM, re-MI, TLR, TVR
91  2019 Losartan Reverses Hippocampal Increase of Kynurenic Acid in Type 1 Diabetic Rats: A Novel Procognitive Aspect of Sartan Action. DM, KYNA
92  2019 Management of a patient with heart failure by sacubitril/valsartan: improvement of functional capacity. ARNIs, HF, HFrEF, NEP, NYHA
93  2019 Mineralocorticoid Antagonism and Diabetic Kidney Disease. ACE, DKD, GLP-1, MRAs, RAAS, SGLT2, T2D
94  2019 Novel mutations in patients with X-linked Alport syndrome: Two case reports. AS
95  2019 Observational Study of Brain Atrophy and Cognitive Decline Comparing a Sample of Community-Dwelling People Taking Angiotensin Converting Enzyme Inhibitors and Angiotensin Receptor Blockers Over Time. ACEI, T2D
96  2019 Olmesartan is not associated with the risk of enteropathy: a Korean nationwide observational cohort study. ACEIs, CI
97  2019 Olmesartan Medoxomil, An Angiotensin II-Receptor Blocker, Ameliorates Renal Injury In db/db Mice. DM, DN, ESRD, OM, STZ
98  2019 Olmesartan-induced Enteropathy: A Rare Side Effect of a Common Medication. ---
99  2019 Pharmacokinetic and haemodynamic interactions between amlodipine and losartan in human beings. CCB, CI, GMR
100  2019 Predictors of in-hospital mortality in very eldery patients presenting with acute coronary syndrome: A single-center study. ACEI, ACS, CI, EF, GRACE, OR